Mizan Review: Prices, Lot Records, COAs, and What We Found
We checked Mizan's complete strength catalog, public lot records, Freedom Diagnostics PDFs and Janoshik reports, keeping measured content and modified peptide forms distinct.
We examined Mizan, its product-strength options and public lot records on November 1, 2026. Its useful feature is the connection between a particular strength, a named lot and laboratory documents filed under the vendor’s own client names. We checked those documents and their laboratory credentials rather than treating a COA tab as proof of every size or test.
Reviewed November 1, 2026. At the November 1 review, PeptideBenchmark had no affiliate, coupon, sponsorship or paid-placement relationship with Mizan. We reviewed public product information, laboratory documents and an anonymous cart; we did not purchase or independently test a vial. Products are labeled for laboratory research only, not human or animal use. This is a commercial-transparency and documentary-evidence review, not medical advice.
Affiliate update — November 6, 2026: PeptideBenchmark is now an approved Mizan affiliate. Our referral link applies BENCHMARK for 10% off products. Anonymous carts confirmed the code on the displayed sale price; BPC-157 10 mg was $25.20 in merchandise after the code, versus $28 without it. We may earn commission on qualifying purchases. This later relationship does not change the review date, laboratory findings or evidence score. Current coupon details are kept separately from the historical prices below.
The documentation we checked
The testing page explains the lot-record system. We examined all 31 publicly listed lot records and the 43 distinct documents linked from them and the corresponding product strengths. Extra endotoxin and heavy-metal reports belong to the same lot; they are not additional products with COAs.
23 documents were Freedom Diagnostics PDFs. Each named Mizan Supply, carried an accession and search code, and matched the laboratory-hosted PDF byte for byte. 20 were Janoshik report images, naming mizansupply.com as the client. Their printed QR codes and published lot links supplied the exact task and unique key used to confirm the report at Janoshik. An exact laboratory lookup confirms that report; it is separate from the byte-for-byte PDF comparison used for Freedom.
At the November 1 review, the reports covered 31 of 37 published strength options. This included all 29 then-available comparable compound-vial offers, plus the 10 mL water and ten-vial 2 mL water-kit options. NAD+ is a coenzyme rather than a peptide; it remains a separately labeled research-compound comparison.
Six options had no linked report at the November 1 review: Wolverine Blend 5 mg + 5 mg; CJC-1295 no DAC / Ipamorelin 5 mg + 5 mg; MZN-3P/Cagri 12.5 mg + 2.5 mg; MZN-1P 5 mg; MZN-1P 10 mg; and 30 mL water. The five compound options were unavailable and were included in that dated catalog count; they were not active offers missing reports.
Catalog clarification — November 6, 2026: Mizan confirmed that these five compound options were out of stock, said it had unlisted them to avoid confusion, and stated that new COAs would accompany their return to stock. Our follow-up confirmed that Wolverine 5 mg + 5 mg was removed from its product’s strength options and the other four options were no longer listed in the shop. Those four options still had directly accessible pages marked out of stock. All 29 available comparable compound-vial offers continued to have linked reports. The current profile retains publicly accessible unavailable options in its catalog coverage; the November 1 figures above are historical.
30 mL water clarification — November 6, 2026: Mizan says this option is an official, manufacturer-sealed Hospira bacteriostatic water vial. A branded manufacturer-sealed diluent should be considered separately from COA coverage for Mizan’s research compounds. The manufacturer and seal description is vendor-supplied; we have not inspected a purchased vial. We record it as Mizan’s clarification, without counting that statement as a laboratory report or treating a separate compound-purity report as a requirement for this supply item.
The comparable vial offers available at review time had lot-specific reports, and the laboratory credentials check out. Certificates describe submitted samples. They do not independently establish every shipped vial's contents, sterility or suitability for use.
Purity, measured content and additional panels
The average reported compound purity was approximately 99.55% across 28 primary purity reports. Separate safety-panel documents and solvent analysis do not enter that average. The NAD+ report states identity and measured amount without publishing a purity percentage; we did not invent one.
Measured content is distinct from the nominal label. For example, the N-Acetyl Selank Amidate lot links Freedom report Miza2610140102, which reports 9.29 mg against the product’s 10 mg nominal label, alongside 99.78% purity. That result remains visible. A high purity percentage does not establish that the labeled mass was recovered.
Six compound options had both endotoxin and heavy-metal reports. A separate heavy-metal report was also published for the 2 mL water-kit lot. We found no compendial sterility report in the reviewed set. Some Janoshik endotoxin results are stated below the assay’s validated range with an estimate; those qualifications matter and are retained in the source document. An endotoxin result is not a sterility test.
Chemical forms and prices
We recorded 29 active single-vial offers across 22 compound groups from 27 product families and 37 strength options. At that review, five unavailable compound options were documented outside active offers, and three water/supply options were outside peptide-mass comparisons. No products were left with an unexplained dose or price deferral.
MZN-3P, MZN-2P and MZN-1P are vendor product codes. The published chemical identifiers support their alignment with retatrutide, tirzepatide and semaglutide respectively; unavailable semaglutide strengths do not become current offers. The blend labels state their nominal component amounts, so a 10 mg + 10 mg blend is compared as 20 mg total blend mass.
Modified forms need their own comparisons. Selank and Semax are explicitly N-acetyl amidates. The Epitalon page publishes Ac-Ala-Glu-Asp-Gly-NH2 and a molecular weight of 431.40 g/mol, so this is kept apart from unmodified Epitalon. Mizan’s full-length thymosin beta-4 page publishes the full-length formula and mass. Its separate 17–23 fragment page publishes Leu-Lys-Lys-Thr-Glu-Thr-Gln, C36H66N10O13 and 847.0 g/mol; that unacetylated form is kept apart from acetylated fragment offers. These are vendor-published structural specifications, not independent sequencing of a purchased vial.
At review time the storefront advertised a 20% fall sale through November 30. The lower prices were already the publicly listed single-vial prices. Examples included BPC-157 10 mg at $28, GHK-Cu 100 mg at $36, and KLOW 80 mg at $70.40. We did not deduct another 20% from those prices.
The product pages also publish quantity tiers. An anonymous BPC-157 cart with five vials charged $26.60 per vial. The comparison rows in this review use the single-vial offer; bulk tiers and an unapproved affiliate code were not compounded into those original rows. The dated affiliate update above describes the later approved code.
Shipping, location and reputation
The shipping policy lists U.S.-only delivery, dispatch within one to two business days, standard shipping at $10, expedited at $15, express at $45, and free standard shipping from $200 after discounts. It excludes territories, PO boxes and military/diplomatic addresses. These are dated vendor terms, not independently tested delivery performance.
The returns policy says products cannot be returned after shipment, with a replacement/refund process for lost or damaged orders and cancellation before dispatch. The storefront publishes 1014 E Cambridge Dr, Schererville, IN 46375, contact@mizansupply.com and 219-281-0990. Our map uses the published contact city; it does not certify a headquarters or fulfillment facility.
The exact-domain Trustpilot refresh returned no profile during onboarding. No unrelated similarly named business or storefront testimonial is substituted for an independent reputation score.
The living Mizan profile carries current scores and evidence counts. Read individual documents in the Mizan COA records, compare current offers on Pricing, and inspect comparable quantities in Stack Builder. The benchmark methodology explains how public documents, laboratory verification and catalog coverage enter the score.
Common questions
Does Mizan publish independently checkable laboratory reports?
Yes. Our November 1, 2026 review covered 43 documents: 23 Freedom Diagnostics PDFs that matched laboratory copies and 20 Janoshik reports confirmed with their exact task and unique key. The client names were Mizan Supply and mizansupply.com.
Does every Mizan strength have a report?
At the November 1 review, reports covered all 29 available comparable compound-vial offers, plus two water options. Five unavailable compound options had no linked report. In a November 6 follow-up, Mizan said those options were out of stock and unlisted pending new COAs when restocked. Mizan also identified the 30 mL water as a manufacturer-sealed Hospira vial; that is a vendor statement, not an independently authenticated purchase. Separate safety reports do not count as extra covered products.
Are Mizan's modified peptides compared with the unmodified versions?
No. N-Acetyl Selank Amidate, N-Acetyl Semax Amidate and the published N-acetylated Epitalon amidate form use separate groups. Full-length thymosin beta-4 is also kept apart from Mizan's unacetylated 17–23 fragment. These distinctions follow the published chemical specifications.
Does PeptideBenchmark have a Mizan affiliate code?
Yes. Affiliate update November 6, 2026: BENCHMARK gives 10% off products, and the referral link applies the code. PeptideBenchmark may earn commission. The relationship was established after the November 1 evidence review and does not change its laboratory findings or score.